Search Results

Human papillomaviruses, or HPVs, are a group of more than 200 related viruses, some of which are linked to cancer. There are about 30 HPV types that can be easily passed between partners through sexual contact, and two of these viruses are responsible for more than 70 percent of cervical cancer cases. In addition to…

Lindsey is a Licensed Clinical Social Worker (LCSW-C) with over 15 years of experience working with oncology patients and their families. She is a certified oncology social worker (OSW-C) and has received specialized training in Meaning-Centered Psychotherapy. Lindsey has worked in diverse clinical environments, including both inpatient and outpatient care, and more recently, as an…

Ari Elman, MD, is a board-certified medical oncologist and hematologist at Maryland Oncology Hematology. He earned his medical degree from the University of Maryland School of Medicine before completing a residency in internal medicine at Temple University Hospital. He went on to serve as chief resident and academic hospitalist at Lankenau Medical Center. In 2016,…

A Phase 3, Randomized, Open-Label, Multicenter, Controlled Study To Evaluate The Efficacy And Safety Of Zanidatamab In Combination With Physician’s Choice Chemotherapy Compared To Trastuzumab In Combination With Physician’s Choice Chemotherapy For The Treatment Of Participants With Metastatic HER2-Positive Breast Cancer Who Have Progressed On, Or Are Intolerant To, Previous Trastuzumab Deruxtecan Treatment (EmpowHER-303)

A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) with or without Durvalumab compared with Investigator’s Choice of Chemotherapy (Paclitaxel/Nab-paclitaxel or Gemcitabine+ Carboplatin) in combination with Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer